China Ophthalmology Focus

China Ophthalmology Focus Limited focuses on the ophthalmology market in Asia. The company has 21 ongoing R&D programs, including 9 innovative compounds and 12 generic drugs, covering dry eye disease, glaucoma, wet age-related macular degeneration (AMD), corneal diseases, and ocular inflammatory diseases.